Source: Annual Congress 2009 - From cough to sound analysis of breathing
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Fukuhara, J. Saito, Y. Sato, T. Nikaido, Y. Inokoshi, K. Saito, N. Nakagawa, T. Ishii, S. Sato, X. Wang, Y. Tanino, T. Ishida, M. Munakata (Fukushima, Japan). Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms. Eur Respir J 2009; 34: Suppl. 53, 261

Member's Comments

No comment yet.

Related content which might interest you: Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006 Rint, exhaled nitric oxide and the prediction of asthma and respiratory symptoms in children Source: Eur Respir J 2005; 26: Suppl. 49, 479s Year: 2005 Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001 Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Clinical utility of fractional exhaled nitric oxide in severe asthma management Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019 Year: 2020 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Salt chamber treatment had no effect on fractional exhaled nitric oxide (FeNO) in patients with symptoms suggesting asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Determine the relationship between fraction exhaled nitric oxide (FeNO) and mannitol challenge test in the diagnosis of suspected asthma patients. Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020 Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA) Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Factors associated with elevated exhaled nitric oxide fraction in infants with recurrent respiratory symptoms Source: Eur Respir J 2013; 41: 189-194 Year: 2013 The relationship between fractional exhaled nitric oxide and asthma symptom scores in patients on mepolizumab Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004 High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007